QIAGEN
QIAGEN Appoints Jonathan M. Pratt Chief Executive Officer
QIAGEN announced a leadership change on August 24, 2026. QIAGEN announced that Jonathan M. Pratt, most recently President and CEO of Filtration Group, has been appointed Chief Executive Officer effective September 1, 2026, succeeding Thierry Bernard.
What changed
Jonathan M. Pratt was named Chief Executive Officer. Thierry Bernard will step down as CEO and Managing Director and will support an orderly transition through the end of the year.
- Leader: Jonathan M. Pratt
- Role: Chief Executive Officer
- Effective: September 1, 2026
- Announcement date: August 24, 2026
Leadership background
Pratt most recently served as President and CEO of Filtration Group, leading the business through the completion of its sale to Parker-Hannifin Corporation in August 2026. Earlier roles include Senior Vice President of the Waters Division at Waters Corporation, President of Beckman Coulter Life Sciences, a Danaher operating company, and senior leadership positions at Pall Corporation. The company said he has more than 25 years of international leadership experience across life sciences, laboratory technologies and healthcare.
The mandate
Pratt said his first priority will be to listen to QIAGEN teams and customers, learn more about the business and understand where the company can sharpen its choices and strengthen execution. Supervisory Board Chairman Stephen H. Rusckowski said the board is confident Pratt will advance the company’s commitment to solid profitable growth.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: QIAGEN leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started